Skip to content

Adaptive Biotechnologies ADPT Increase Decrease In Operating Lease Right Of Use Assets And Liabilities

Increase Decrease In Operating Lease Right Of Use Assets And Liabilities at other companies

ArcBest logo
ArcBestARCB
$34K-99.7%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
-$1.52M-32.1%
Primoris Services logo
Primoris ServicesPRIM
$3.2M+60.0%
V.F. Corporation logo
V.F. CorporationVFC
$87.49M-3.8%
Advance Auto Parts logo
Advance Auto PartsAAP
-$24M+52.0%
EPR Properties logo
EPR PropertiesEPR
-$520K-77.5%

Other financials

Income statement

See full
Revenue$70.9M+35.1%
Gross profit$52.2M+47.1%
Operating income-$19.2M+35.1%
Net income-$20.0M+32.9%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$77.6M+53.2%
Total debt$208.2M-5.6%
Total equity$216.3M+13.6%
Total assets$505.9M-1.0%

Cash flow

See full
Operating cash flow-$9.5M+66.5%
CapEx$796.0K-36.8%
Free cash flow-$10.3M+65.3%

Valuation

See full
Market cap$2.76B+93.6%
Enterprise value$2.89B+78.0%
P/S9.3×+1.8×

Profitability

See full
Gross margin75.3%+12.7pp
Operating margin-15.8%-7.0pp
Net margin-16.8%-7.3pp
FCF margin-10.5%-4.6pp

Returns & leverage

See full
Return on equity-24.4%-9.2pp
Debt / equity-0.2×
Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept adpt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's increase decrease in operating lease right of use assets and liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Adaptive Biotechnologies's increase decrease in operating lease right of use assets and liabilities?
Adaptive Biotechnologies (ADPT) reported increase decrease in operating lease right of use assets and liabilities of -$2.6M in Q1 2026.
How has Adaptive Biotechnologies's increase decrease in operating lease right of use assets and liabilities changed year-over-year?
Adaptive Biotechnologies's increase decrease in operating lease right of use assets and liabilities decreased by 27.8% year-over-year, from -$2.04M to -$2.6M.
What is the long-term trend for Adaptive Biotechnologies's increase decrease in operating lease right of use assets and liabilities?
Over 3 years (2022 to 2025), Adaptive Biotechnologies's increase decrease in operating lease right of use assets and liabilities has grown at a 37.2% compound annual growth rate (CAGR), from -$4.05M to -$10.45M.
What does increase decrease in operating lease right of use assets and liabilities mean?
This metric captures the net change in operating lease liabilities and the corresponding right-of-use assets during the period. It reflects the cash impact of lease obligations and the non-cash adjustments related to lease accounting standards. Monitoring this helps investors understand the company's underlying lease commitments and their impact on operating cash flow.